Correction: Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer.
Main Author: | PLOS ONE Staff |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4390372?pdf=render |
Similar Items
-
Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer.
by: Tanja Lucas, et al.
Published: (2015-01-01) -
Correction: Protection against Enterovirus 71 with Neutralizing Epitope Incorporation within Adenovirus Type 3 Hexon
by: Xingui Tian, et al.
Published: (2012-01-01) -
Correction: Protection against Enterovirus 71 with Neutralizing Epitope Incorporation within Adenovirus Type 3 Hexon.
by: Xingui Tian, et al.
Published: (2012-01-01) -
Human Adenovirus Serotype 3 Vector Packaged by a Rare Serotype 14 Hexon.
by: Xiaobo Su, et al.
Published: (2016-01-01) -
Hexons from adenovirus serotypes 5 and 48 differentially protect adenovirus vectors from neutralization by mouse and human serum.
by: Andrew W Harmon, et al.
Published: (2018-01-01)